| 8318762 |
Pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Richard Elliott, Kevin Daniel Freeman-Cook, David A. Griffith, Dennis Paul Phillion |
2012-11-27 |
$617,530,000 |
| 7250418 |
Compounds as CRF1 receptor antagonists |
Michael Ennis, Kristine E. Frank, Jian-Min Fu, Robert Louis Hoffman, Patrick Robert Verhoest |
2007-07-31 |
$138,124,000 |
| 7087617 |
Substituted pyrimidine derivatives |
Michael Ennis, Kristine E. Frank, Jian-Min Fu, Robert Louis Hoffman, Patrick Robert Verhoest |
2006-08-08 |
$496,056,000 |
| 7041672 |
Substituted aryl 1, 4-pyrazine derivatives |
Patrick Robert Verhoest, Michael Ennis, Kristine E. Frank, Jian-Min Fu, Robert Louis Hoffman |
2006-05-09 |
$303,797,000 |
| 7015229 |
Substituted pyrimidinones and pyrimidinthiones |
Jian-Min Fu, Michael Ennis, Kristine E. Frank, Robert Louis Hoffman, Patrick Robert Verhoest |
2006-03-21 |
$488,876,000 |
| 6992087 |
Substituted aryl 1,4-pyrazine derivatives |
Patrick Robert Verhoest, Robert Louis Hoffman, Michael Ennis, Kristine E. Frank, Jian-Min Fu |
2006-01-31 |
$204,261,000 |
| 6964965 |
Substituted pyrazine derivatives |
Michael Ennis, Kristine E. Frank, Jian-Min Fu, Robert Louis Hoffman, Patrick Robert Verhoest |
2005-11-15 |
$134,651,000 |
| 6849620 |
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
Daniel Walker, Eric Jon Jacobsen, David W. Piotrowski, Brad Acker, Donn Wishka +2 more |
2005-02-01 |
$221,993,000 |
| 6599916 |
Quinuclidine-substituted heteroaryl moieties for treatment of disease |
Jason K. Myers, Bruce N. Rogers, Vincent Groppi, David W. Piotrowski, Alice L. Bodnar +1 more |
2003-07-29 |
|
| 6562816 |
Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease |
Donn Wishka, Jason K. Myers, Bruce N. Rogers, Eric Jon Jacobsen, David W. Piotrowski +2 more |
2003-05-13 |
|
| 6500840 |
Quinuclidine-substituted heteroaryl moieties for treatment of disease |
Jason K. Myers, Bruce N. Rogers, Vincent Groppi, David W. Piotrowski, Alice L. Bodnar +1 more |
2002-12-31 |
$106,947,000 |
| 6492385 |
Quinuclidine-substituted heteroaryl moieties for treatment of disease |
Jason K. Myers, Bruce N. Rogers, Vincent Groppi, David W. Piotrowski, Alice L. Bodnar +1 more |
2002-12-10 |
$104,261,000 |
| 6423718 |
4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors |
Soo S. Ko |
2002-07-23 |
$356,960,000 |
| 6127375 |
4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinthiones useful as HIV reverse transcriptase inhibitors |
— |
2000-10-03 |
$708,415,000 |
| 6124302 |
4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors |
Soo S. Ko |
2000-09-26 |
$285,743,000 |
